Alerts will be sent to your verified email
Verify EmailSAROJA
Saroja Pharma Ind
|
Norris Medicines
|
Link Pharma Chem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
33.33 % | 47.03 % | 4.87 % |
5yr average Equity Multiplier
|
4.66 | -2.46 | 1.96 |
5yr Average Asset Turnover Ratio
|
2.98 | 0.6 | 1.37 |
5yr Avg Net Profit Margin
|
2.08 % | -30.66 % | 1.5 % |
Price to Book
|
0.0 | 0.0 | 1.09 |
P/E
|
17.9 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
80.28 Days | 97.28 Days | 74.76 Days |
Inventory Days
|
11.27 Days | 165.43 Days | 54.27 Days |
Days Receivable
|
122.72 Days | 69.98 Days | 53.6 Days |
Days Payable
|
47.62 Days | 260.51 Days | 92.46 Days |
5yr Average Interest Coverage Ratio
|
2.76 | -1.37 | 3.51 |
5yr Avg ROCE
|
37.65 % | -19.87 % | 8.64 % |
5yr Avg Operating Profit Margin
|
4.76 % | -6.94 % | 5.7 % |
5 yr average Debt to Equity
|
1.78 | -3.0 | 0.46 |
5yr CAGR Net Profit
|
3.81 % | -15.97 % | n/a |
5yr Average Return on Assets
|
6.13 % | -18.92 % | 2.49 % |
Shareholdings
|
|||
Promoter Holding
|
73.02 % | 34.0 % | 51.49 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Saroja Pharma Ind
|
Norris Medicines
|
Link Pharma Chem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|